Biotech IPOs and Investor Relations

Biotech IPOs and Investor Relations

Biotech IPOs and Investor Relations was born out of a desire to provide pragmatic, insightful, and jargon-free guidance to biotech entrepreneurs – individuals who are striving to bring new therapies to underserved patient populations. By demystifying Wall Street for this already overburdened group of scientists and risk-takers, the author aims to make a small contribution toward their goals – principally, helping patients live longer, better lives. The book took just under two years to write. It contains a significant portion of what was learned over a nearly three-decade career, spanning both equity research and investor relations.

Whether you are a first-time (or experienced) biotech CEO, CFO, CMO, CSO, CCO, CBO, IRO, founder, employee, investor, analyst, banker, lawyer, auditor, or consultant, you will find within these pages answers to many of the questions you may previously have been reluctant to ask.

Published: April 2026

Co-Authors: Laurence Watts